CD38 and plasma cell myeloma: In this sense, it has also been reported that extramedullary myeloma cells lose the expression of CD38 [38, 39], suggesting that CD38 down-regulation may facilitate the migration of malignant plasma cells to peripheral blood or extramedullary sites.